Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China

Congenital heart disease (CHD), a wide spectrum of diseases with varied outcomes, is the most common congenital malformation worldwide. In this Series of three papers, we describe the burden of CHD in China; the development of screening, diagnosis, treatment, and follow-up strategies; and challenges associated with the disease. We also propose solutions and recommendations for policies and actions to improve the outcomes of CHD. In the first paper in this Series, we focus on prenatal and neonatal screening, diagnosis, and management of CHD. Based on advanced international knowledge, the Chinese Government has developed a network system comprising prenatal screening, diagnosis of CHD subtypes, specialist consultation appointments, and treatment centres for CHD. A new professional discipline, fetal cardiology, has been formed and rapidly developed. Consequently, the overall coverage of prenatal and neonatal screening and the accuracy of CHD diagnoses have gradually improved, and the neonatal CHD mortality rate has decreased substantially. However, China still faces several challenges in the prevention and treatment of CHD, such as insufficient diagnostic capabilities and unqualified consultation services in some regions and rural areas.

Automated summary

In this series of papers, the burden of congenital heart disease (CHD) in China is described, along with the development of screening, diagnosis, treatment, and follow-up strategies, and the associated challenges. Solutions and recommendations are proposed to improve the outcomes of CHD. Despite progress in prenatal and neonatal screening, diagnosis, and management of CHD in China, challenges remain such as insufficient diagnostic capabilities and unqualified consultation services in some regions and rural areas.